94 related articles for article (PubMed ID: 29937447)
1. Evaluation of a novel clinicopathological marker JK-1 for human oesophageal carcinoma.
Tang JC; Chan KW; Law SY
Hong Kong Med J; 2018 Jun; 24 Suppl 3(3):41-44. PubMed ID: 29937447
[No Abstract] [Full Text] [Related]
2. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma.
Gotoda T; Matsumura Y; Kondo H; Ono H; Kanamoto A; Kato H; Watanabe H; Tachimori Y; Nakanishi Y; Kakizoe T
Gut; 2000 Jan; 46(1):14-9. PubMed ID: 10601048
[TBL] [Abstract][Full Text] [Related]
3. Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma.
Rosato A; Pivetta M; Parenti A; Iaderosa GA; Zoso A; Milan G; Mandruzzato S; Del Bianco P; Ruol A; Zaninotto G; Zanovello P
Int J Cancer; 2006 Oct; 119(7):1717-22. PubMed ID: 16671090
[TBL] [Abstract][Full Text] [Related]
4. Expression of apoptosis-related proteins caspase-6, caspase-9, FLIP and BNIP3 in oesophageal squamous cell carcinomas.
Oh JE; Kim MS; Kang MR; Kim YR; Kim HS; Yoo NJ; Lee SH
Pathology; 2010; 42(5):492-3. PubMed ID: 20632834
[No Abstract] [Full Text] [Related]
5. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker.
Turner JR; Odze RD; Crum CP; Resnick MB
Hum Pathol; 1997 Jun; 28(6):740-4. PubMed ID: 9191010
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
Kalinina T; Bockhorn M; Kaifi JT; Thieltges S; Güngör C; Effenberger KE; Strelow A; Reichelt U; Sauter G; Pantel K; Izbicki JR; Yekebas EF
Int J Cancer; 2010 Oct; 127(8):1931-40. PubMed ID: 20104520
[TBL] [Abstract][Full Text] [Related]
7. TAOS1, a novel marker for advanced esophageal squamous cell carcinoma.
Komatsu Y; Hibi K; Kodera Y; Akiyama S; Ito K; Nakao A
Anticancer Res; 2006; 26(3A):2029-32. PubMed ID: 16827140
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Guo YL; Shan BE; Guo W; Dong ZM; Zhou Z; Shen SP; Guo X; Liang J; Kuang G
J Biomed Sci; 2017 Jan; 24(1):6. PubMed ID: 28077137
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion.
Zhang H; Xu L; Xiao D; Xie J; Zeng H; Wang Z; Zhang X; Niu Y; Shen Z; Shen J; Wu X; Li E
J Clin Pathol; 2007 May; 60(5):555-61. PubMed ID: 17412867
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of angiopoietin-like protein 4 expression in oesophageal squamous cell carcinoma.
Shibata K; Nakayama T; Hirakawa H; Hidaka S; Nagayasu T
J Clin Pathol; 2010 Dec; 63(12):1054-8. PubMed ID: 20861003
[TBL] [Abstract][Full Text] [Related]
11. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.
Nishioka K; Doki Y; Shiozaki H; Yamamoto H; Tamura S; Yasuda T; Fujiwara Y; Yano M; Miyata H; Kishi K; Nakagawa H; Shamma A; Monden M
Br J Cancer; 2001 Aug; 85(3):412-21. PubMed ID: 11487274
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological significance of expressions of RECK and MMP-2 in esophageal squamous carcinoma].
Qi M; Li JS; Li Y
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):283-5. PubMed ID: 20510080
[TBL] [Abstract][Full Text] [Related]
14. Expression of cysteine-rich 61 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma.
Xie JJ; Xu LY; Wu ZY; Li LY; Xu XE; Wu JY; Huang Q; Li EM
Eur J Surg Oncol; 2011 Aug; 37(8):669-74. PubMed ID: 21664098
[TBL] [Abstract][Full Text] [Related]
15. An overview of esophageal squamous cell carcinoma proteomics.
Qi YJ; Chao WX; Chiu JF
J Proteomics; 2012 Jun; 75(11):3129-37. PubMed ID: 22564818
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 and retinoblastoma protein expression in oesophageal squamous cell carcinoma.
Chetty R; Chetty S
Mol Pathol; 1997 Oct; 50(5):257-60. PubMed ID: 9497916
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis.
Yuen HF; Chan YP; Wong ML; Kwok WK; Chan KK; Lee PY; Srivastava G; Law SY; Wong YC; Wang X; Chan KW
J Clin Pathol; 2007 May; 60(5):510-4. PubMed ID: 16822877
[TBL] [Abstract][Full Text] [Related]
18. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
19. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of KLK13 promotes the invasiveness and metastasis of oesophageal squamous cell carcinoma.
Lin Q; Mao W; Wu Q; He X; Li S; Fan Y; Chen J; Feng T; Cao X
Biomed Pharmacother; 2017 Dec; 96():1008-1015. PubMed ID: 29221724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
